Phathom Pharmaceuticals shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Phathom Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Phathom Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Phathom Pharmaceuticals by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $827k | 70k | 11.77 |
| 2024-12-31 | $123k | 15k | 8.11 |
| 2024-09-30 | $273k | 15k | 18.10 |
| 2024-06-30 | $303k | 29k | 10.30 |
| 2024-03-31 | $151k | 14k | 10.65 |
| 2023-09-30 | $1.3M | 122k | 10.37 |
| 2023-06-30 | $772k | 54k | 14.32 |
| 2023-03-31 | $144k | 20k | 7.12 |
| 2022-12-31 | $208k | 19k | 11.23 |
| 2020-12-31 | $727k | 22k | 33.24 |